[Phase II clinical trial of autologous dendritic cell vaccine with immunologic adjuvant in cutaneous melanoma patients].
Baldueva IA, Novik AV, Moiseenko VM, Nekhaeva TL, Danilova AB, Danilov AO, Protsenko SA, Petrova TIu, Uleĭskaia GI, Shchekina LA, Semenova AI, Mikhaĭlichenko TD, Teletaeva GM, Zhabina AS, Volkov NV, Komarov IuI.
Baldueva IA, et al. Among authors: novik av.
Vopr Onkol. 2012;58(2):212-21.
Vopr Onkol. 2012.
PMID: 22774527
Clinical Trial.
Russian.